Abstract
The application of polymers in medicine, as components of drug carriers, as well as their synthetic strategies are considered essential for producing and developing new drug formulations against human deceases. The synthesis of block copolymers is a timeconsuming process with a high cost of the final product, although several block copolymer systems have been already commercialized successfully. The biocompatibility, the biodegradability and the non toxic profile of newly synthesized polymers towards healthy tissues, should be taken into account in order to be acceptable for biomedical applications. In this review article, focus is placed on new approaches and synthetic strategies for preparing novel block copolymers and their utilization as parts of new and advanced Drug Delivery nanoSystems (aDDnSs) with a Modulatory Controlled Release profile (MCR). Such complex and advanced nanosystems can alter the pharmacokinetic properties of the encapsulated drug and consequently its effectiveness. Emphasis is given to the use of living polymerization methodologies and post polymerization chemical transformation reactions for the synthesis of mainly diblock copolymers for novel drug delivery nanosystems. Issues related to self-assembly of block copolymers in solution toward formation of colloidal functional nanostructures that can serve as nanocontainers and nanocarriers, and strategies for controlling encapsulation of specific drugs are also discussed. Specific examples are reported mainly on diblock copolymer systems, including authors’ recent work.
Keywords: Block copolymers, nanomedicine, micelles, nanocarriers, drug encapsulation, advanced drug delivery nanosystems, polymer synthesis, self-assembly, controlled polymerizations, nanotechnology
Current Medicinal Chemistry
Title:Block Copolymers for Drug Delivery Nano Systems (DDnSs)
Volume: 19 Issue: 29
Author(s): E. Kaditi, G. Mountrichas, S. Pispas and C. Demetzos
Affiliation:
Keywords: Block copolymers, nanomedicine, micelles, nanocarriers, drug encapsulation, advanced drug delivery nanosystems, polymer synthesis, self-assembly, controlled polymerizations, nanotechnology
Abstract: The application of polymers in medicine, as components of drug carriers, as well as their synthetic strategies are considered essential for producing and developing new drug formulations against human deceases. The synthesis of block copolymers is a timeconsuming process with a high cost of the final product, although several block copolymer systems have been already commercialized successfully. The biocompatibility, the biodegradability and the non toxic profile of newly synthesized polymers towards healthy tissues, should be taken into account in order to be acceptable for biomedical applications. In this review article, focus is placed on new approaches and synthetic strategies for preparing novel block copolymers and their utilization as parts of new and advanced Drug Delivery nanoSystems (aDDnSs) with a Modulatory Controlled Release profile (MCR). Such complex and advanced nanosystems can alter the pharmacokinetic properties of the encapsulated drug and consequently its effectiveness. Emphasis is given to the use of living polymerization methodologies and post polymerization chemical transformation reactions for the synthesis of mainly diblock copolymers for novel drug delivery nanosystems. Issues related to self-assembly of block copolymers in solution toward formation of colloidal functional nanostructures that can serve as nanocontainers and nanocarriers, and strategies for controlling encapsulation of specific drugs are also discussed. Specific examples are reported mainly on diblock copolymer systems, including authors’ recent work.
Export Options
About this article
Cite this article as:
Kaditi E., Mountrichas G., Pispas S. and Demetzos C., Block Copolymers for Drug Delivery Nano Systems (DDnSs), Current Medicinal Chemistry 2012; 19 (29) . https://dx.doi.org/10.2174/0929867311209025088
DOI https://dx.doi.org/10.2174/0929867311209025088 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiproliferative and Proapoptotic Effects of the TrK-inhibitor GW441756 in Human Myosarcomas and Prostatic Carcinoma
Current Signal Transduction Therapy Polymorphisms of Genes Encoding Phase I Enzymes in Mexican Americans – An Ethnic Comparison Study
Current Pharmacogenomics Is there a Possible Single Mediator in Modulating Neuroendocrine–thymus Interaction in Ageing?
Current Aging Science Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Current Pharmaceutical Design Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress
Current Topics in Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists
Current Medicinal Chemistry The True Face of the Revolution in Oncology Drug Development: A Personal Reflection
Current Clinical Pharmacology Application of Carbon Nanotubes In Drug Delivery of Non-cancerous Diseases: A Review
Current Pharmaceutical Design Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets Neuroprotective Role of Natural Polyphenols
Current Topics in Medicinal Chemistry Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening Ras-Induced Senescence and its Physiological Relevance in Cancer
Current Cancer Drug Targets Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms
Mini-Reviews in Medicinal Chemistry Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Recent Patents on Anti-Cancer Drug Discovery Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Dibenzoylmethane Activates Nrf2-Dependent Detoxification Pathway and Inhibits Benzo(a)pyrene Induced DNA Adducts in Lungs
Medicinal Chemistry